News

Under the deal, Tramorgan has secured the exclusive marketing sales and distribution rights of Innovus’ topical consumer care product to increase penile sensitivity. The deal has an initial

The company said that the trial failed to meet its primary endpoint of non-inferiority; however, the results showed that HbA1c was reduced for patients on either regimen, to

The once-weekly subcutaneous injection, Trulicity is designed to improve glycemic control (blood sugar levels), along with diet and exercise, in these patients. Trulicity is not recommended as first-line

The NIAID has exercised two additional options under its contract with BioCryst, which provides for GMP drug substance and drug product manufacture of BCX4430. So far, BioCryst has

The application passed the preliminary examination of the PRC State Intellectual Property Bureau and was accepted for review; the application acceptance number is 201410182757.7. The filed patent is

The Supervisory Board unanimously approved the Board of Management’s plans today, Thursday. "Our intention is to create two top global corporations: Bayer as a world-class innovation company in

ZEVALIN is used in the treatment of non-Hodgkin’s lymphoma (NHL) and MARQIBO is used in the treatment of acute lymphoblastic leukemia (ALL). CE melphalan has met the endpoints

Founded in 2003, HMT is a global leader in the emerging fields of metabolomics and systems biology. HMT will apply their proprietary, state-of-the-art capillary electrophoresis-mass spectrometry (CE-MS) technologies

The study will be conducted by way of a biOasis grant to the Brains for Brain Foundation ("B4B") of Padova, Italy, headed by renowned Lysosomal Storage Disease expert,